Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use KOĀTE® safely and effectively. See full prescribing information for KOĀTE. KOĀTE®, Antihemophilic Factor (Human)Lyophilized Powder for Solution for Intravenous InjectionInitial U.S. Approval: 1974
Medication labelWhy this: Advisory · dailymed-other
KOĀTE® is a human plasma-derived antihemophilic factor indicated for the control and prevention of bleeding episodes or in order to perform emergency and elective surgery in patients with hemophilia A (hereditary Factor VIII deficiency). Limitation of Use KOĀTE is not indicated for the treatment of von Willebrand disease.
- generic_name
- antihemophilic factor (human)
- brand_name
- Water
- product_names
- Antihemophilic Factor (Human), Water
- ndc
- 76125-250, 76125-252, 76125-661, 76125-667, 76125-672, 76125-675, 76125-253, 76125-258, 76125-669, 76125-662, 76125-673, 76125-674, 76297-002, 76125-250-20, 76125-252-21, 13533-000, 13533-000-04, 76125-253-25, 13533-200, 13533-200-05, 76125-258-02, 76297-002-02, 76125-667-30, 76125-669-31, 76125-662-50, 76125-661-02, 76125-672-50, 76125-673-51, 13533-000-05, 76125-674-10, 13533-200-10, 76125-675-12, 76297-002-12
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en